BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 517 filers reported holding BIO-TECHNE CORP in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $379,253 | +10.0% | 4,646 | 0.0% | 0.02% | +4.5% |
| Q1 2023 | $344,687 | +91328.9% | 4,646 | +2.0% | 0.02% | +4.8% |
| Q4 2022 | $377 | -99.9% | 4,554 | +287.2% | 0.02% | 0.0% |
| Q3 2022 | $334,000 | -6.2% | 1,176 | +14.5% | 0.02% | 0.0% |
| Q2 2022 | $356,000 | -20.0% | 1,027 | 0.0% | 0.02% | -8.7% |
| Q1 2022 | $445,000 | -24.8% | 1,027 | -10.3% | 0.02% | +9.5% |
| Q4 2021 | $592,000 | +9.6% | 1,145 | +2.7% | 0.02% | +10.5% |
| Q3 2021 | $540,000 | +7.6% | 1,115 | 0.0% | 0.02% | +11.8% |
| Q2 2021 | $502,000 | -82.5% | 1,115 | -85.1% | 0.02% | -81.9% |
| Q1 2021 | $2,868,000 | -23.2% | 7,508 | -36.1% | 0.09% | -35.6% |
| Q4 2020 | $3,733,000 | +15.3% | 11,756 | -10.0% | 0.15% | -7.0% |
| Q3 2020 | $3,238,000 | -7.1% | 13,069 | -1.0% | 0.16% | -7.6% |
| Q2 2020 | $3,486,000 | +22.6% | 13,201 | -11.9% | 0.17% | +6.2% |
| Q1 2020 | $2,843,000 | -13.6% | 14,992 | 0.0% | 0.16% | +29.0% |
| Q4 2019 | $3,291,000 | +9.7% | 14,992 | -2.2% | 0.12% | 0.0% |
| Q3 2019 | $3,000,000 | -6.3% | 15,331 | -0.2% | 0.12% | -1.6% |
| Q2 2019 | $3,203,000 | +4.7% | 15,364 | -0.3% | 0.13% | +2.4% |
| Q1 2019 | $3,059,000 | -46.5% | 15,407 | -53.0% | 0.12% | +4.2% |
| Q4 2018 | $5,721,000 | +70.8% | 32,798 | +99.8% | 0.12% | -7.1% |
| Q3 2018 | $3,350,000 | +36.7% | 16,412 | -0.9% | 0.13% | +27.0% |
| Q2 2018 | $2,451,000 | -7.6% | 16,569 | -5.7% | 0.10% | -11.5% |
| Q1 2018 | $2,653,000 | +18.2% | 17,564 | +1.3% | 0.11% | +21.5% |
| Q4 2017 | $2,245,000 | -36.5% | 17,332 | -40.7% | 0.09% | -34.0% |
| Q3 2017 | $3,535,000 | – | 29,238 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
| Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
| STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
| DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
| Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
| MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
| Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
| GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
| Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
| CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |